The FDA Encourages New Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration is collaborating with patients, academics, and the pharmaceutical industry to encourage the development of new treatments for sickle cell disease (SCD).

from FDA Consumer Health Information Updates https://ift.tt/2xgZVOC
via IFTTT